Status:
WITHDRAWN
Ciprofloxacin for the Prevention of Meningococcal Meningitis 2018
Lead Sponsor:
Epicentre
Collaborating Sponsors:
Medecins Sans Frontieres, Netherlands
Conditions:
Meningitis, Meningococcal
Eligibility:
All Genders
Phase:
PHASE4
Brief Summary
The trial is an interventional, cluster-randomized trial to assess the impact of oral ciprofloxacin for household and community contacts of meningitis cases on the incidence of meningitis during an ep...
Detailed Description
The study is designed as a cluster-randomized trial in the setting of a meningitis epidemic to assess the impact of chemoprophylaxis with single-dose ciprofloxacin on the incidence of meningitis in th...
Eligibility Criteria
Inclusion
- Resident in a village included in the study area
Exclusion
- Patients currently exhibiting symptoms of meningitis (to be immediately referred for further care)
- Persons with a known allergy to fluoroquinolone antibiotics.
Key Trial Info
Start Date :
March 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03431675
Start Date
March 1 2019
End Date
December 31 2019
Last Update
August 14 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Madarounfa Health District
Madarounfa, Maradi Region, Niger